BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

JACOBS LEVY EQUITY MANAGEMENT, INC's Holding History (CIK: 0000884414)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,031,488 Value ($000) $8,046 Avg Close $7.23 Range $6.00 - $8.17
Q3 2025
Shares 370,463 Value ($000) $2,812 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 381,480 Value ($000) $3,418 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 276,859 Value ($000) $2,076 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 247,795 Value ($000) $1,863 Avg Close $7.59 Range $6.85 - $8.44
Q3 2024
Shares 367,514 Value ($000) $2,793 Avg Close $7.60 Range $6.17 - $8.88
Q2 2024
Shares 739,599 Value ($000) $4,571 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 156,119 Value ($000) $793 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 96,397 Value ($000) $577 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 470,137 Value ($000) $3,329 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 1,155,723 Value ($000) $8,136 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 2,034,343 Value ($000) $16,966 Avg Close $9.63 Range $7.82 - $12.08
Q4 2022
Shares 1,468,106 Value ($000) $16,854 Avg Close $12.47 Range $10.36 - $14.50
Q3 2022
Shares 416,526 Value ($000) $5,248 Avg Close $12.87 Range $10.33 - $15.43
Q2 2020
Shares 75,363 Value ($000) $359 Avg Close $3.99 Range $1.80 - $6.29
Q1 2020
Shares 18,100 Value ($000) $36 Avg Close $2.75 Range $1.58 - $4.35
Q4 2019
Shares 2,116,417 Value ($000) $7,302 Avg Close $2.52 Range $1.38 - $3.48
Q3 2019
Shares 1,627,785 Value ($000) $4,664 Avg Close $3.11 Range $2.49 - $3.98
Q2 2013
Shares 70,400 Value ($000) $109 Avg Close $1.73 Range $1.26 - $2.21